G. Hulse

Obstetric and neonatal outcomes associated with maternal naltrexone exposure

C. Brewer, G. Hulse, G. O'Neill, 2001, The Australian & New Zealand journal of obstetrics & gynaecology.

Blood naltrexone and 6‐ß‐naltrexol levels following naltrexone implant: comparing two naltrexone implants

G. Hulse, D. Arnold-Reed, P. O'Neil, 2004, Addiction biology.

A possible role for implantable naltrexone in the management of the high‐risk pregnant heroin user

G. Hulse, G. O'Neill, 2002, The Australian & New Zealand journal of obstetrics & gynaecology.

Achieving long‐term continuous blood naltrexone and 6‐ß‐naltrexol coverage following sequential naltrexone implants

G. O'neil, C-T Chan, R. Hansson, 2004, Addiction biology.

Serum ionic dysequilibria in clinical opioid dependence: Cross-sectional and longitudinal studies

A. Reece, A. Norman, G. Hulse, 2017, Human & experimental toxicology.

Hyperbolic dose reduction of escitalopram mitigates withdrawal syndrome: a case report

G. Hulse, AT Gallo, 2022, Psychiatry Research Case Reports.

Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user

G. Hulse, D. Arnold‐Reed, G. O’Neil, 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.